IKT — INHIBIKASE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 111 SEC-registered investment managers reported holding IKT (INHIBIKASE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $250.86M across 123.70M shares. That is +5.2% by share count (+5.84M shares) versus the previous quarter, while reported value moved +27.0%. Ownership is concentrated: the five largest holders account for 39.9% of reported value and the top ten for 63.8%.
Compared with the prior quarter, 21 opened new positions, 49 added to existing stakes, 23 trimmed, 17 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of INHIBIKASE THERAPEUTICS INC (IKT) include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, ranked by reported 13F value among the 165 institutional holders on this page.
IKT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 68 | 55.93M | $115.00M | +5.2% |
| Q2 2026 | 111 | 123.70M | $250.86M | +5.2% |
| Q1 2026 | 107 | 118.52M | $199.00M | +8.0% |
| Q4 2025 | 76 | 106.77M | $218.81M | +38.6% |
| Q3 2025 | 55 | 55.15M | $89.29M | +0.5% |
| Q2 2025 | 50 | 54.70M | $106.60M | +8.1% |
| Q1 2025 | 45 | 52.35M | $114.65M | +2.1% |
| Q4 2024 | 32 | 50.20M | $163.15M | +1510.4% |
Over the 8 quarters shown, institutional share counts increased 11% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+1510.4%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.02M | $26.82M | 3.97% | Hold | |
| 8.56M | $17.60M | 0.00% | Add | |
| 5.85M | $12.02M | 0.29% | Hold | |
| 5.05M | $10.38M | 0.00% | Add | |
| 3.82M | $7.85M | 5.93% | Hold | |
| 3.58M | $7.36M | 1.17% | Hold | |
| 3.06M | $6.30M | 0.00% | Add | |
| 2.22M | $4.57M | 0.00% | Add | |
| 1.95M | $4.01M | 0.18% | Reduce | |
| 1.37M | $2.81M | 0.50% | New | |
| 984.37K | $2.02M | 0.00% | Add | |
| 721.96K | $1.48M | 0.96% | Add | |
| 681.10K | $1.40M | 0.00% | Add | |
| 647.28K | $1.33M | 1.02% | Add | |
| 621.57K | $1.28M | 0.00% | Add | |
| 510.60K | $1.05M | 0.00% | Hold | |
| 417.04K | $857.02K | 0.00% | Reduce | |
| 333.91K | $686.19K | 0.00% | Add | |
| 321.04K | $648.49K | 0.00% | Add | |
| 293.73K | $603.62K | 0.00% | Add | |
| 190.54K | $392.51K | 0.00% | Add | |
| 183.55K | $377.19K | 0.00% | Add | |
| 155.95K | $320.48K | 0.00% | Hold | |
| 128.83K | $264.74K | 0.00% | Add | |
| 120.09K | $246.77K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.95M | $17.74M | 3.89% | Hold | |
| 6.33M | $10.25M | 0.52% | Hold | |
| 6.12M | $9.92M | 0.89% | Hold | |
| 5.42M | $8.78M | 0.27% | Hold | |
| 5.40M | $8.74M | 0.43% | Hold | |
| 5.25M | $8.50M | 0.87% | Add | |
| 3.27M | $5.30M | 0.00% | Add | |
| 3.08M | $4.98M | 0.00% | Add | |
| 2.64M | $4.27M | 0.02% | Hold | |
| 2.19M | $3.55M | 0.14% | Hold | |
| 1.11M | $1.80M | 0.00% | Add | |
| 735.02K | $1.19M | 0.97% | Hold | |
| 507.75K | $822.55K | 0.00% | Add | |
| 374.34K | $606.42K | 0.00% | Reduce | |
| 152.95K | $247.78K | 0.00% | Reduce | |
| 152.30K | $246.72K | 0.00% | Hold | |
| 152.30K | $246.72K | 0.00% | Hold | |
| 138.67K | $224.64K | 0.00% | Add | |
| 136.28K | $220.77K | 0.00% | Add | |
| 105.77K | $171.35K | 0.00% | Reduce | |
| 85.58K | $138.64K | 0.00% | Reduce | |
| 80.50K | $130.40K | 0.00% | New | |
| 78.66K | $127.43K | 0.00% | Hold | |
| 71.67K | $116.11K | 0.00% | New | |
| 57.55K | $93.23K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.95M | $21.35M | 4.21% | Hold | |
| 6.33M | $12.33M | 0.82% | Hold | |
| 6.12M | $11.94M | 1.55% | Hold | |
| 5.43M | $10.59M | 0.39% | Reduce | |
| 5.40M | $10.53M | 0.74% | Add | |
| 5.12M | $9.99M | 1.67% | Hold | |
| 3.22M | $6.29M | 0.00% | Add | |
| 2.73M | $5.32M | 0.00% | Add | |
| 2.64M | $5.14M | 0.02% | Add | |
| 2.19M | $4.27M | 0.19% | Hold | |
| 1.07M | $2.08M | 0.00% | Add | |
| 733.79K | $1.43M | 1.49% | Reduce | |
| 397.81K | $775.73K | 0.00% | Add | |
| 392.72K | $765.80K | 0.00% | Add | |
| 383.07K | $746.99K | 0.00% | Reduce | |
| 156.95K | $306.06K | 0.00% | Add | |
| 152.30K | $296.98K | 0.00% | New | |
| 152.30K | $296.98K | 0.00% | New | |
| 144.24K | $281.27K | 0.00% | New | |
| 132.47K | $258.32K | 0.00% | New | |
| 110.25K | $214.99K | 0.00% | Add | |
| 99.68K | $194.37K | 0.00% | Add | |
| 78.66K | $153.38K | 0.00% | New | |
| 60.70K | $118.36K | 0.00% | New | |
| 58.52K | $114.12K | 0.00% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.61M sh · $5.29M
- SPHERA FUNDS MANAGEMENT LTD. 649.31K sh · $1.32M
- Kennondale Capital Management LLC 565.98K sh · $1.15M
- Pathstone Holdings, LLC 510.60K sh · $1.04M
- Sixth Street Partners Management Company, L.P. 275.04K sh · $558.33K
- ALPS ADVISORS INC 134.00K sh · $272.02K
- AMERICAN CENTURY COMPANIES INC 49.00K sh · $99.47K
- Cerity Partners LLC 38.01K sh · $77.17K
- Mariner, LLC 23.14K sh · $46.97K
- Sanctuary Advisors, LLC 22.80K sh · $46.29K
- Neuberger Berman Group LLC 21.29K sh · $43.23K
- Lynx1 Capital Management LP 20.00K sh · $40.60K
Fully Exited (vs previous quarter)
- PERCEPTIVE ADVISORS LLC sold 2.31M sh · $3.89M
- STATE STREET CORP sold 1.69M sh · $2.83M
- Ally Bridge Group (NY) LLC sold 1.32M sh · $2.23M
- ALGERT GLOBAL LLC sold 133.83K sh · $224.83K
- Point72 Asset Management sold 40.38K sh · $67.84K
- FIFTH LANE CAPITAL, LP sold 24.90K sh · $41.83K
- Virtu Financial LLC sold 24.61K sh · $41.00K
- CCG WEALTH MANAGEMENT, LLC sold 24.12K sh · $40.52K
- Balyasny Asset Management sold 17.67K sh · $29.69K
- Renaissance Technologies sold 16.50K sh · $27.72K
- CWM, LLC sold 16.42K sh · $27.58K
- SG Americas Securities, LLC sold 15.48K sh · $26.00K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 13.02M | 13.02M | 13.02M | 13.02M | 10.95M | 10.95M | 10.95M | 10.95M | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 8.56M | 7.77M | 6.30M | 3.31M | 3.08M | 2.73M | 423.98K | 335.46K | — | — | — | — | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 5.85M | 5.85M | 5.85M | 5.85M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.05M | 4.94M | 4.45M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 3.82M | 3.82M | 3.82M | 1.75M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Spruce Street Capital LP | 3.58M | 3.58M | 3.58M | 3.58M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.06M | 2.61M | 2.17M | 1.13M | 1.11M | 1.07M | 324.76K | 322.88K | 50.06K | 37.33K | 28.69K | 28.69K | 28.69K | 14.84K | 89.05K | 89.05K | 89.23K | 89.23K | 84.21K | 79.13K |
| STATE STREET CORP | 2.22M | — | 1.69M | 554.85K | 507.75K | 397.81K | 41.88K | 41.88K | 10.08K | 10.08K | 10.08K | 10.08K | 10.08K | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 1.95M | 2.70M | 2.70M | 3.93M | 2.19M | 2.19M | 2.19M | 2.19M | — | — | — | — | — | — | — | — | — | — | — | — |
| Tyro Capital Management LLC | 1.37M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 984.37K | 809.49K | 617.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kennondale Capital Management LLC | 721.96K | 565.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 681.10K | 607.26K | 567.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 647.28K | 396.18K | 957.20K | 2.35M | 735.02K | 733.79K | 914.97K | 1.13M | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 621.57K | 204.65K | 228.15K | 94.55K | 136.28K | 38.67K | 45.27K | 27.53K | 4.87K | — | 3.21K | — | 149 | — | — | 130 | 7.50K | — | 5.11K | 1.76K |
| Pathstone Holdings, LLC | 510.60K | 510.60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 417.04K | 425.49K | 472.40K | 78.66K | 78.66K | 78.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 333.91K | 303.13K | 213.21K | 137.49K | 138.67K | 132.47K | — | — | — | — | — | — | — | — | 39.01K | 39.01K | 39.31K | 39.31K | 39.58K | 39.58K |
| JPMorgan Chase & Co | 321.04K | 316.57K | 328.52K | 24.85K | 49.94K | 28.58K | — | — | — | — | — | — | 5 | 2 | — | — | — | — | — | — |
| Morgan Stanley | 293.73K | 114.01K | 164.26K | 79.68K | 56.02K | 99.68K | 21.65K | 7.30K | 1.67K | 1.67K | 1.67K | 1.67K | 1.67K | 1.67K | 10.00K | 10.00K | 10.00K | 10.00K | — | 2 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold IKT?
As of 2026-Q2, 111 institutional funds reported holding IKT (INHIBIKASE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $250.86M.
How many shares of IKT do institutions own?
13F filers reported 123.70M shares of IKT, worth $250.86M in aggregate at the end of 2026-Q2.
Is institutional ownership of IKT rising or falling?
Share counts moved +5.2% versus the prior quarter — accumulation.
Who are the top institutional holders of IKT?
The largest 13F holders are Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, BlackRock Inc, Fairmount Funds Management LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of INHIBIKASE THERAPEUTICS INC?
The major shareholders of INHIBIKASE THERAPEUTICS INC (IKT) by reported 13F value are Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, BlackRock Inc, Fairmount Funds Management LLC, among 165 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.